Emergency Action is Necessary to Provide Payment for Pharmacist Prescribing of Paxlovid

APhA needs your assistance to ensure you can effectively care for you patients. Reach out to your Member of Congress and Senators and ask them to take immediate action to provide adequate, appropriate, and fair payment for pharmacist consultations and services for prescribing Paxlovid.

Act now  

APhA’s Learning Library

We’re excited to announce the launch of the new APhA Learning Library! This new platform will make it easier than ever for you to get the education you need. Read about some key highlights of our new system.

Learn more  

Community Pharmacy Workplace Summit

APhA is committed to facilitating meaningful dialogue between pharmacy management, pharmacy team members, and other stakeholders that result in improved workplaces, well-being, and ability to meet ethical obligations to patient safety.

Learn more  

Featured Education

Upcoming Events

Practice Resources

Tools and resources to support your practice

Access Now  


Latest from APhA

View CEO Blog

Ilisa Bernstein's Letter to the FDA Regarding Pharmacists Prescribing Oral COVID-19 Treatments

A letter from Interim CEO Ilisa Bernstein, PharmD, JD, FAPhA, to Dr. Robert Califf, Commissioner of the Food and Drug Administration (FDA), on the importance of pharmacists being allowed to prescribe oral COVID-19 treatments.


APhA and NASPA Release Third Pharmacy Workplace and Well-being Reporting (PWWR) Findings

WASHINGTON, DC—Today the American Pharmacists Association (APhA) and the National Alliance of State Pharmacy Associations (NASPA) released the third installment of the Pharmacy Workplace and Well-being Reporting (PWWR) trends and findings report series.


Pharmacy news

View all news

Number of states with high rates of adult obesity more than doubles

New CDC data show that 19 states and 2 territories have at least 35% of residents with adult obesity. That figure is more than two times the number of states with high adult obesity prevalence recorded in 2018.

NIH releases study on diabetes medications

An NIH-backed study reported in 2 papers in the New England Journal of Medicine shows that the diabetes treatments insulin glargine and liraglutide more effectively maintain target blood sugar levels than sitagliptin or glimepiride when added to first-line metformin.